Personalized Medicine Requires Complex Supply Chains: Marken

Outsourcing-Pharma and Nina Vas, Marken’s Vice President, Clinical Distribution, Cell and Gene Therapy Supply Chain, discuss the specific requirements involved in the clinical trial supply chain for cell and gene therapies and other personalized medicines, which differs dramatically from small molecule therapies and requires an appropriately personalized approach.

Read Full Article